Saori Furuta (IMAGE) DOE/Lawrence Berkeley National Laboratory Caption Saori Furuta, Berkeley Lab’s Life Sciences Division was part of a study that linked the FAM83A protein to the resistance of breast cancer to the therapeutic drugs known as EGFR-TKIs. Credit Robert Lee Del Chiaro Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.